Product Categories
| Country: | China |
|---|---|
| Tel: | 021-65675885 |
| Mobile: | 18964387627 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Tilavonemab | 2096513-89-0 | Details |
| Spesolimab | 2097104-58-8 | Details |
| HBED-CC-tris(tert-butyl ester) | C38H56N2O10 | 2097123-80-1 | Details |
| Garetosmab | 2097125-54-5 | Details |
| Pepinemab | 2097151-87-4 | Details |
| Aneratrigine hydrochloride | 2097163-75-0 | Details |
| BCL6-IN-7 | C18H15ClN6O | 2097518-46-0 | Details |
| OBI-3424 | C21H25N4O6P | 2097713-68-1 | Details |
| MLT-747 | C20H21Cl2N7O3 | 2097853-86-4 | Details |
| Anatibant 2HCl | 209788-45-4 | Details |
| Stafib-2 | C28H26N2O12P2 | 2097938-74-2 | Details |
| I-138 | C26H23F3N6O | 2098211-50-6 | Details |
| Zastaprazan | C22H26N4O | 2133852-18-1 | Details |
| Epcoritamab | 2134641-34-0 | Details |
| Cantrixil | C24H24O6 | 2135511-22-5 | Details |
| GSK3182571 | C25H31ClN8O | 2135595-04-7 | Details |
| Atoltivimab | 2135632-29-8 | Details |
| Odesivimab | 2135632-30-1 | Details |
| Maftivimab | 2135632-36-7 | Details |
| (-)-JNJ-A07 | C28H26ClF3N2O6 | 2135640-92-3 | Details |
| (+)-JNJ-A07 | C28H26ClF3N2O6 | 2135640-93-4 | Details |
| DN401 | C13H9BrClN5O2 | 2135749-60-7 | Details |
| SPOP-IN-6lc | 2136270-56-7 | Details |
| Disitamab vedotin | 2136633-23-1 | Details |
| Canocapavir | C27H21BrFN5O3 | 2137847-19-7 | Details |
| USP1-IN-2 | C26H22F4N6O | 2098212-05-4 | Details |
| Budigalimab | 2098225-93-3 | Details |
| Zampilimab | 2098280-42-1 | Details |
| Nimacimab | 2098636-09-8 | Details |
| Betrixaban-d6 | C23H22ClN5O3 | 2098655-51-5 | Details |
| Abelacimab | 2098724-83-3 | Details |
| Sanguinarine citrate | C20H14NO4.C6H7O7 | 2098782-69-3 | Details |
| Se-DMC | C13H15ClO3Se | 2098850-81-6 | Details |
| Lenumlostat | C18H17F4N3O3 | 2098884-52-5 | Details |
| CDK4/6/1 Inhibitor | C28H30F2N6 | 2099128-41-1 | Details |
| AT-121 hydrochloride | C24H39ClN4O3S | 2099681-71-5 | Details |
| Bis-PEG4-t-butyl ester | C20H38O8 | 2100306-53-2 | Details |
| CM03 | C34H44N6O6 | 2101208-44-8 | Details |
| Elipovimab | 2101210-43-7 | Details |
| Cephalexin-d5 | C16H7D10N3O4S | 2101505-56-8 | Details |
| (R)-Pirtobrutinib | C22H21F4N5O3 | 2101700-14-3 | Details |
| VU6000918 | C18H17F2N5OS | 2101737-32-8 | Details |
| Glenzocimab | 2101829-58-5 | Details |
| INT. 2 | 210193-42-3 | Details |
| Enpatoran hydrochloride | C16H16ClF3N4 | 2101945-93-9 | Details |
| Envafolimab | 2102192-68-5 | Details |
| MK-6884 | C25H25N5O | 2102194-04-5 | Details |
| Naph-EA-mal | C22H21N3O4 | 210292-65-2 | Details |
| Taprizosin | C25H26N6O4S | 210538-44-6 | Details |
| Narsoplimab | 2108782-45-0 | Details |
| Edonentan | C28H32N4O5S | 210891-04-6 | Details |
| Benufutamab | 2109730-69-8 | Details |
| LY382884 | C18H23NO4 | 211566-75-5 | Details |
| Lodapolimab | 2118349-31-6 | Details |
| 11-oxo-alpha-amyrin | C30H48O2 | 2118-90-3 | Details |
| Teclistamab | 2119595-80-9 | Details |
| 3-OMFP Cyclohexylammonium salt | C27H28NO8P | 21233-09-0 | Details |
| Duostatin 5 | C40H69N9O6 | 2124210-34-8 | Details |
| Fianlimab | 2126132-98-5 | Details |
| Telazorlimab | 2126777-87-3 | Details |
| CYP4A11/CYP4F2-IN-2 | C16H20N4O2 | 2126874-77-7 | Details |
| SIRT5 inhibitor 3 | C22H12FN3O4 | 2128651-12-5 | Details |
| Tetrahymanol | C30H52O | 2130-17-8 | Details |
| BCL6-IN-8c | C20H20ClN3O5 | 2130878-25-8 | Details |
| YW2036 | C20H16N4O | 2131223-92-0 | Details |
| Aurora kinase inhibitor-8 | C30H29N7O3 | 2133001-88-2 | Details |
| 8-Azaguanosine | C9H12N6O5 | 2133-80-4 | Details |
| Olinvacimab | 2095504-49-5 | Details |
| RIP1 kinase inhibitor 1 | C24H20ClN5O3 | 2095515-38-9 | Details |
| (S)-ZINC-3573 | C18H21N5 | 2095596-11-3 | Details |
| Pozelimab | 2096328-94-6 | Details |
| Vibecotamab | 2138442-13-2 | Details |
| Plamotamab | 2138442-31-4 | Details |
| Boc-NH-PEG4-C2-Boc | C20H39NO8 | 2138484-13-4 | Details |
| 2-(3,4-Dihydroxyphenyl)-1,3-benzodioxole-5-carboxaldehyde | C14H10O5 | 213903-67-4 | Details |
| AMPD2 inhibitor 1 | C25H22N2O2 | 2139356-35-5 | Details |
| Serclutamab | 2140172-41-2 | Details |
| Prucalopride-13C-d3 | C18H23ClD3N3O3 | 2140306-00-7 | Details |
| Daminozide-d6 (dimethyl-d6) | C6H12N2O3 | 2140327-55-3 | Details |
| RAGE 229 | C23H22N4O2 | 2143072-85-7 | Details |
| Olaparib-d5 | C24H23FN4O3 | 2143107-56-4 | Details |
| MDH1-IN-1 | C21H25NO4 | 2143463-31-2 | Details |
| MDH1-IN-2 | C25H33NO5 | 2143463-35-6 | Details |
| Cirtuvivint | C24H25N7O | 2143917-62-6 | Details |
| Orexin 2 Receptor Agonist 2 | C23H33FN2O4S | 2114324-60-4 | Details |
| LFHP-1c | C55H64N6O4 | 2102347-47-5 | Details |
| Pacmilimab | 2145091-51-4 | Details |
| Praluzatamab | 2145109-70-0 | Details |
| Diayangambin | C24H30O8 | 21453-68-9 | Details |
| Bivatuzumab | 214559-60-1 | Details |
| DS28120313 | C16H17N5O2 | 2146177-09-3 | Details |
| Efalizumab | 214745-43-4 | Details |
| L-Cysteine-d3 | C3H4D3NO2S | 214782-32-8 | Details |
| FmocNH-PEG4-t-butyl ester | C30H41NO8 | 2148295-94-5 | Details |
| Zalifrelimab | 2148321-69-9 | Details |
| Tidutamab | 2148354-90-7 | Details |
| Cendakimab | 2151032-62-9 | Details |
| Ocarocoxib | C12 H6 F6 O4 | 215122-22-8 | Details |
| SC-75416 | C15H14ClF3O3 | 215122-74-0 | Details |
| MPT0G211 | C17H15N3O2 | 2151853-97-1 | Details |
| Product Total： Product Page： | ||||
| 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 | ||||